1a,25-dihydroxy vitamin D3 has a major role in the regulation of the bone metabolism as it promotes the expression of key bone-related proteins in osteoblastic cells. In recent years it has become increasingly evident that in addition to its well-established genomic actions, 1a,25-dihydroxy vitamin
Secondary hyperparathyroidism in hypovitaminosis D is more rapidly suppressed by the administration of 1,25-dihydroxy-vitamin D3 than by vitamin D3
✍ Scribed by R. Theiler; H. Bischoff; G. Somorjai; A. Tyndall; H. B. Stäbelin
- Publisher
- Springer-Verlag
- Year
- 1996
- Tongue
- English
- Weight
- 119 KB
- Volume
- 6
- Category
- Article
- ISSN
- 0937-941X
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Abstract In ROS 17/2.8 rat osteoblastic‐like cells a capacitative Ca^2+^ entry (CCE) pathway operates which is activated by either 1α,25‐dihydroxy‐vitamin D~3~ (1α,25(OH)~2~D~3~) or thapsigargin (Tpg)‐induced depletion of Ca^2+^ stores (Baldi et al. [2002]: J. Cell. Biochem. 86:678–687). In view
The active form of vitamin D(3), 1,25-dihydroxyvitamin D(3) (1,25(OH)(2)D(3)), induces caspase-independent apoptosis in MCF-7 and T47D breast cancer cells. Before the appearance of apoptotic cells at Day 4 after the addition of 1,25(OH)(2)D(3), the MCF-7 cells are sensitized to the caspase-mediated